Dopaminergic mechanisms regulating prolactin secretion in patients with prolactin-secreting pituitary adenoma. Long-term studies after selective transsphenoidal surgery
- PMID: 6813636
- DOI: 10.1016/0026-0495(82)90159-7
Dopaminergic mechanisms regulating prolactin secretion in patients with prolactin-secreting pituitary adenoma. Long-term studies after selective transsphenoidal surgery
Abstract
Twenty-seven female patients with prolactin-secreting pituitary microadenoma, were studied at different intervals following selective transsphenoidal removal of the tumor. Postoperatively, all patients had normal prolactin (PRL) levels and regular menstrual cycles were restored. Sixteen of 27 patients showed positive responses to TRH and metoclopramide (MCP) within 1 mo after surgery. On the contrary, 9 patients showed evaluation of these patients demonstrated that normal neuroendocrine relationships were restored after several months since positive PRL responses to TRH and MCP could be elicited in such patients. The remaining 2 patients who showed basal PRL levels in the upper range of normal, exhibited negative responses to TRH and MCP. These patients had progressively to TRH and MCP exhibited 10-20 mo after surgery a normal decrease in PRL levels following administration of carbidopa plus L-Dopa. Negative responses to carbidopa plus L-Dopa were instead obtained in 6 postoperative patients with elevated PRL levels and negative responses to TRH and MCP. These results suggest that: 1) Hyperprolactinemia induced by "autonomous" pituitary adenomas increases hypothaLamic dopamine (DA) secretion, which in turn inhibits PRL secretion by nonadenomatous lactotropes. 2) Total selective removal of the microadenoma acutely decreases PRL concentration, but a functional inhibition of the normal lactotrope can persist for a period of few months following surgery in a certain number of patients. 3) Prolonged reduction of PRL concentration is accompanied to a normal DA tone with reestablishment of normal neuroendocrine relationships.
Similar articles
-
Prolactin-secreting pituitary adenomas: prolactin dynamics before and after transsphenoidal surgery.Acta Endocrinol (Copenh). 1979 Jul;91(3):397-409. doi: 10.1530/acta.0.0910397. Acta Endocrinol (Copenh). 1979. PMID: 112818
-
Serum prolactin response to thyrotropin-releasing hormone and metoclopramide in patients with prolactin-secreting tumors before and after transsphenoidal surgery.J Clin Endocrinol Metab. 1978 Nov;47(5):1148-51. doi: 10.1210/jcem-47-5-1148. J Clin Endocrinol Metab. 1978. PMID: 122421
-
Evaluation of dopaminergic tone in hyperprolactinemia. III. Thyroid-stimulating hormone response to metoclopramide in differential diagnosis and postoperative follow-up of prolactinoma patients.Metabolism. 1985 Oct;34(10):917-22. doi: 10.1016/0026-0495(85)90138-6. Metabolism. 1985. PMID: 4046835
-
Prolactin and pituitary tumors.Curr Top Exp Endocrinol. 1978;3:131-72. doi: 10.1016/b978-0-12-153203-1.50011-0. Curr Top Exp Endocrinol. 1978. PMID: 26521 Review. No abstract available.
-
Growth factors in pituitary tumors.Pituitary. 1999 May;1(3-4):153-8. doi: 10.1023/a:1009996712678. Pituitary. 1999. PMID: 11081193 Review.
Cited by
-
Treatment of hyperprolactinemia: a systematic review and meta-analysis.Syst Rev. 2012 Jul 24;1:33. doi: 10.1186/2046-4053-1-33. Syst Rev. 2012. PMID: 22828169 Free PMC article.
-
Reappraising the Role of Trans-Sphenoidal Surgery in Prolactin-Secreting Pituitary Tumors.Cancers (Basel). 2021 Jun 29;13(13):3252. doi: 10.3390/cancers13133252. Cancers (Basel). 2021. PMID: 34209686 Free PMC article.
-
Enlarged adenomectomy for enclosed prolactinomas: a preliminary study of 26 cases.Acta Neurochir (Wien). 1990;103(3-4):92-8. doi: 10.1007/BF01407512. Acta Neurochir (Wien). 1990. PMID: 2399846
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous